IP Library Granted Patent US 7,521,548
Granted Patent B2
US 7,521,548 · App. 10/071,174 · Granted Apr 21, 2009

Apoptosis modulator Bcl-B and methods for making and using same

Assignee: Burnham Institute for Medical Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,521,548
App. No.
10/071,174
Granted
Apr 21, 2009
Kind
B2
Abstract

A novel human member of the Bcl-2 family Bcl-B has been identified, which is closest in amino-acid sequence homology to the Boo (Diva) protein. The Bcl-B protein is widely expressed in adult human tissues. The Bcl-B protein modulates apoptosis. Bcl-B also binds Bcl-2, BCI-XL, and Bax but not Bak. Bcl-B displays a unique pattern of selectivity for binding and regulating the function of other members of the Bcl-2 family.

Claims (15)

1. An isolated or recombinant nucleic acid comprising a polynucleotide sequence that is 95% or more identical to SEQ ID NO:1, wherein said polynucleotide sequence encodes a polypeptide that is an apoptosis inhibitor.

2. The isolated or recombinant nucleic acid of claim 1 , that is 95% identical to SEQ ID NO:1.

3. The isolated or recombinant nucleic acid of claim 1 , wherein the sequence is attached to a substrate.

4. An expression cassette, comprising a polynucleotide sequence that is 95% or more identical to SEQ ID NO:1 operably linked to an expression control element, wherein said polynucleotide sequence encodes a polypeptide that inhibits apoptosis.

5. The expression cassette of claim 4 , wherein the expression control element comprises a promoter or enhancer.

6. The expression cassette of claim 4 , wherein the expression control element is constitutive, inducible, tissue-specific or developmentally related.

7. A vector comprising the expression cassette of claim 4 .

8. The vector of claim 7 wherein said vector confers expression in bacteria, plant, insect, mammalian, or yeast cells.

9. The vector of claim 7 wherein said vector is a viral vector.

10. The viral vector of claim 9 wherein said vector said vector is an adenoviral vector.

11. The vector of claim 7 wherein said vector wherein the polypeptide encoded by the expression cassette comprises SEQ ID NO:2.

12. An isolated transformed cell comprising the nucleic acid of claim 1 .

13. The isolated transformed cell of claim 12 , wherein the cell is a bacteria, plant, insect, mammalian or yeast cell.

14. The isolated transformed cell of claim 12 , where the cell is a mammalian cell and where the mammalian cell is human.

15. A method of producing a polypeptide comprising expressing a nucleic acid sequence that is at least 95% identical to SEQ ID NO:1, wherein the nucleic acid sequence encodes a polypeptide that inhibits apoptosis and said nucleic acid is expressed in solution, or in a cell in vitro.

Assignments (4)
CONFIRMATORY LICENSE Recorded Nov 13, 2019
From: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 050997/0861 →
CONFIRMATORY LICENSE Recorded Jun 4, 2008
From: THE BURNHAM INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021038/0078 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2005
From: REED, JOHN C.; KE, NING; GODZIK, ADAM
To: THE BUMHAM INSTITUTE
Reel/Frame 016683/0982 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2002
From: REED, JOHN C.; KE, NING; GODZIK, ADAM
To: BURNHAM INSTITUTE, THE
Reel/Frame 013104/0250 →
Continuity (2)
Provisional Application 6026716600 · Feb 7, 2001
Related Publication 20030176671A1 · Sep 18, 2003